ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
5 announcements with these filters
Thyrocare agreed to sell its entire stake in subsidiary Nueclear Healthcare to Trovera. The consideration is about Rs 141.40 Crore, including preference shares and cash.
Thyrocare's board approved sale of 100% in Nueclear Healthcare to Trovera for ~₹141.40 Crore. The move exits radiology to refocus on core pathology business.
NCLT sanctioned the merger of Docon Technologies into API Holdings. Accordingly, the promoter's 51.02% stake in Thyrocare transfers to API Holdings, leaving the aggregate shareholding unchanged.
Thyrocare Technologies' Board has approved an in-principle evaluation of a potential demerger or business transfer involving the radiology undertaking of its subsidiary, Nueclear Healthcare Limited.
Thyrocare Technologies approved a ₹5.50 Crore cash equity infusion into its subsidiary, Think Health Diagnostics. The investment supports working capital and business operations through multiple tranches.